Pharmaceutical Procurement for Indian Army: Diverse Medication Supply Tender

This tender, issued by the Department of Military Affairs under the Ministry of Defence, pertains to the procurement of a comprehensive range of pharmaceutical products for the Indian Army. The bid, identified by number GEM/2026/B/8062369, will commence on September 25, 2026, at 12:23 PM and conclude on October 16, 2026, at 1:00 PM. The scope of supply encompasses a significant total quantity of 564,285 units, covering a diverse list of medications. These include, but are not limited to, Acarbose 25 mg Tablets, Acebrophylline 100mg Plus NAC N-Acetylcysteine 600mg Tablets, Aceclofenac 100mg Plus Paracetamol 325mg Tablets, Aceclofenac 100mg Tablets, Acenocoumarol in 1 mg, 2 mg, and 4 mg strengths, Acetazolamide 250mg Tablets, Acyclovir 400mg Tablets, Acotiamide 100 mg Tablets, Rifaximin 400mg Capsules, Risperidone 2 mg Tablets, Rivastigmine 1.5 mg Capsules, Rizatriptan 5 mg Tablets, Ropinirole in 0.25 mg and 1 mg strengths, Rosuvastatin 10mg Plus Fenofibrate 160 mg Tablets, Rosuvastatin 20mg Tablets, Rosuvastatin 40 mg Tablets, S-Adenosyl Methionine 400mg Tablets, Safinamide 50Mg Tablets, Secnidazole 1 gm Tablets, Serratiopeptidase 5mg Tablets, Sertaconazole Cream 2% in a 30 gms tube, Sertraline in 50 mg and 25mg strengths, and Sevelamer in 400mg and 800 mg strengths. This tender represents a substantial opportunity for suppliers to provide essential pharmaceuticals to a critical defense organization.